Our philosophy is that taking on transformative problems in translational medicine requires collaborative teams made up of engineers, biologists, chemists, and physician-scientists.

As such, we are thrilled to collaborate with colleagues from multiple disciplines. Our lab has the good fortune of interacting with a number of collaborating labs in the Boston area and beyond! Here is a sampling:

Transcriptional regulation in prostate cancer

Steven Balk Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School

Myles Brown Laboratory, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School

Matthew Freedman Laboratory, Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute

Todd Golub Laboratory, Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute

William Hahn Laboratory, Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute

Janssen Pharmaceuticals, Prostate Cancer DAS, Transcend Project

Myc probe discovery

Benjamin Ebert Laboratory, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, Broad Institute

Dean Felsher Laboratory, Stanford School of Medicine, Clinical Cancer Center at Stanford

Charles Lin Laboratory, Baylor College of Medicine, Dan L. Duncan Cancer Center, Center for Drug Discovery

Proteomics Platform, Broad Institute

Myb probe discovery

Alex Kentsis Laboratory, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center

Patrick Ha Laboratory, Department of Otolarynology, UCSF Helen Diller Familiy Comprehensive Cancer Center

John Porco Laboratory, Department of Chemistry, Center for Molecular Discovery, Boston University

Kimberly Stegmaier Laboratory, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Broad Institute

Christopher Vakoc Laboratory, Cold Spring Harbor Laboratory

HMGN1 probe discovery

Andrew Lane Laboratory, Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute

Oncogenic fusion proteins

Christopher Counter Laboratory, Department of Pharmacology and Cancer Biology, Duke University School of Medicine

Cory Johannessen, Broad Institute Cancer Program

Corinne Linardic Laboratory, Department of Pediatrics, Duke University School of Medicine

Tim Reddy Laboratory, Department of Biostatistics & Bioinformatics, Center for Genomic & Computational Biology, Duke University

Beat Schafer Laboratory, Division of Oncology, University Children's Hospital, University of Zurich, Cancer Network Zurich

Jack Shern Laboratory, Pediatric Oncology Branch, National Cancer Institute

Kimberly Stegmaier Laboratory, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Broad Institute

Kris Wood Laboratory, Department of Pharmacology and Cancer Biology, Duke University School of Medicine

Probing post-translational modifications that regulate transcription factor activity

Stuart Schreiber Laboratory, Harvard Chemistry and Chemical Biology, Broad Institute

Targeted drug delivery

Goncalo Bernardes Laboratory, University of Cambridge, Instituto de Medicina Molecular, Universisdade de Lisboa

Arturo Vegas Laboratory,  Boston University